Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bio-Rad Laboratories
(NY:
BIO
)
290.08
-1.80 (-0.62%)
Streaming Delayed Price
Updated: 11:45 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bio-Rad Laboratories
< Previous
1
2
3
4
Next >
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
February 06, 2023
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.
Via
Investor's Business Daily
Thoughts For Thursday: All Eyes On The CPI
January 12, 2023
All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the...
Via
Talk Markets
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
December 07, 2022
Via
Benzinga
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
October 11, 2022
One analyst doubts any deal could come to fruition. If it did, it would make sense.
Via
Investor's Business Daily
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
October 11, 2022
Reuters US-China Chip War: KLA Relaxes Chip Supply To China
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
During Friday, 125 stocks hit new 52-week lows.
Via
Benzinga
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
October 11, 2022
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
Bio-Rad Laboratories: Q2 Earnings Insights
July 28, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Tesla, Danaher And Some Other Big Gainers From Yesterday
July 22, 2022
U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
July 21, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...
Via
Benzinga
Jim Cramer Says This Stock Is 'Too Risky'
July 01, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."
Via
Benzinga
7 Profitable Places to Hide Your Money During a Bear Market
May 13, 2022
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification.
Via
InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
May 02, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
April 28, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Will Investment Gains For Google Parent Reverse In Upcoming Earnings Report?
April 05, 2022
Investment gains have played a big role in earnings beats for GOOGL stock in recent years but that may reverse in its first-quarter earnings.
Via
Investor's Business Daily
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead
March 10, 2022
We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.
Via
InvestorPlace
7 Stocks To Buy at the Bottom After the Market Rout
February 17, 2022
The recent market rout offers an opportune entry point to these seven robust stocks. These are good stocks to buy at their bottom now.
Via
InvestorPlace
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
Recap: Bio-Rad Laboratories Q4 Earnings
February 10, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Bio-Rad Laboratories's Earnings: A Preview
February 09, 2022
Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2022-02-10. Here's what investors need to know before the announcement. Analysts estimate that Bio-Rad...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 24, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
A Look Into Healthcare Sector Value Stocks
November 01, 2021
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.